Immutep Limited’s IMMP share price has dipped by 12.04%, which has investors questioning if this is right time to buy.

The multiple myeloma armamentarium is large and getting larger. That makes treatment choices complex and the cost of ...

A new site to house one of the UK's most secretive research centres is being considered by the government. Hundreds of ...

Researchers found people given a shingles vaccine had a 23% lower risk of cardiovascular events, including stroke, heart ...

Immunosuppression appears to reduce mortality among people with systemic sclerosis with pulmonary arterial hypertension but ...

Mike Hazen had just hung up the phone, having spoken with me about the Diamondbacks’ upcoming “Brain Tumor Awareness Night,” ...

An increasing array of B-cell targeting approaches may aid clinicians in managing the cycles and flares of lupus, according ...

Harvey Jones says the GSK share price has dramatically underperformed FTSE 100 rival AstraZeneca, which has had a stellar run ...

In a report released today, Jo Walton from UBS maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target of ...

Nifty Bank index hit a four-month high at 53,525.15, gaining nearly 1 per cent on the National Stock Exchange (NSE) in Thursday’s intra-day trade in an otherwise subdued market, after strong up move ...